CervoMed logo

CervoMed

CRVO | NASDAQ
Chart Builder DCF Calculator
$1.67
-$0.02 (-1.18%)
At close: Nov 16, 2026, 4:00 PM ET
$1.65
-$0.02 (-1.16%)
After-hours: Nov 16, 2026, 7:58 PM ET
-1.18%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
27.8
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #863/1021 (Top 85%)

Key Statistics

Market Data

Market Cap $25.26M
1D Range
1.65 1.90
52W Range
1.37 9.94

Valuation (TTM)

PE -0.61
PB 1.46
EV/EBITDA -0.20

Valuation (NTM)

Forward PE N/A
Forward PEG 0.02
Price Target $7.00
Loading financial charts...

Profile

CervoMed Inc., a clinical-stage biotechnology company, engages in the development and commercialization of treatments for age-related neurologic disorders. The company is developing neflamapimod, an o...

Sector Healthcare
Industry Biotechnology
Employees 15
IPO Date May 23, 2008
Fiscal Year January - December

Latest News

No news articles available yet.

Earnings

Next Earnings
Mar 12, 2027
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

Analyst Summary

# of Analysts
5
Consensus
Buy
Price Target
$7.00
Upside
+319.16%
Buy (5)
Hold (0)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.